Eye

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

Retrieved on: 
Tuesday, March 12, 2024
Microsoft, Azure, KPMG, Software as a service, Dun & Bradstreet, Organization, Government, Case management, AML, Intelligence, Partnership, Risk, Artificial intelligence, News, Running, AI, EY, PWC, Insurance, Eye, Fraud, Ecosystem, API, Public sector, Telecommunications, Data management, Lighthouse, Sales

LONDON, March 12, 2024 (GLOBE NEWSWIRE) -- Quantexa, a global leader in decision intelligence solutions for the public and private sectors, used the backdrop of QuanCon24, its annual customer and partner conference, to reveal its Decision Intelligence Platform roadmap, and provided an update on Q Assist, a generative artificial intelligence (AI) assistant that previewed in July last year. Quantexa also announced a partnership with Microsoft. Dan Higgins, Quantexa’s Chief Product Officer, was joined by Kate Rosenshine, Global Technology Director, Strategic Partnerships at Microsoft, where they announced the immediate availability of Quantexa’s Decision Intelligence Platform on Microsoft Azure Marketplace and plans to bring a new cloud-native AI solution to mid-size banks in the United States.

Key Points: 
  • Quantexa’s ambitious plan to lead the emerging decision intelligence category is anchored in helping enterprises and government agencies use contextual analytics and AI to improve organization-wide decision making.
  • Quantexa is putting an emphasis on practical, real-world applicability today, with an eye on helping customers plan for future technology deployments.
  • Dan Higgins, Quantexa’s Chief Product Officer, stated, “When it comes to Quantexa’s technology roadmap, we are guided by our client’s needs and leadership ambition in decision intelligence.
  • To meet increasing demand and unique industry complexities, Quantexa showcased advancements in data management, contextual analytics, and AI capabilities.

Procter & Gamble Recalls 8.2 Million Defective Bags of Tide, Gain, Ace and Ariel Laundry Detergent Packets Distributed in US Due to Risk of Serious Injury

Retrieved on: 
Friday, April 5, 2024
Discount, Variety, Parenting, Children, Supermarket, Home Goods, Family, Consumer, Retail, Online Retail, Risk, Eye, Tide Pods, Multimedia, Death, Procter & Gamble, Child, Skin, Medical device

Procter & Gamble (NYSE:PG) today announced a voluntary packaging recall of Tide Pods, Gain Flings, Ace Pods and Ariel Pods liquid laundry detergent packets packaged in flexible film bags.

Key Points: 
  • Procter & Gamble (NYSE:PG) today announced a voluntary packaging recall of Tide Pods, Gain Flings, Ace Pods and Ariel Pods liquid laundry detergent packets packaged in flexible film bags.
  • This recall announcement applies only to bags distributed in the United States.
  • Consumers with recalled bags can submit a photo of the recalled product, showing the lot code, to participate in the recall.
  • Recalled products range from bags with 12 to 39 laundry detergent packets and include the following:

Corti Set to Disrupt the Health Wearable Market with the First Real-time, Continuous Monitor for Cortisol and Melatonin Hormones, the Key Stress and Sleep Hormones

Retrieved on: 
Thursday, April 4, 2024
Wearables, Mobile Technology, Technology, Mental Health, Fitness & Nutrition, Health Technology, Other Health, Health, General Health, Consumer Electronics, Moses Austin, Benchmarking, Hormone, Exercise, Professor, Inflammation, Biomarker, Research, Sleep, Melatonin, University, Doctor of Philosophy, Life, Eye, Diet, Management, Publication, Skin, Cortisol, Ageing, Medical device

The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.

Key Points: 
  • The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.
  • Now, it provides users with unmatched real-time insights into their wellness, establishing a new benchmark for the continuous monitoring of these critical biomarkers.
  • Corti redefines health monitoring by offering continuous, real-time visibility into the body's key stress and sleep hormones, Cortisol and Melatonin, marking a first in the wearable market.
  • Moreover, we are actively working with partnering businesses to discover new applications, enhancing its integration into various health and wellness ecosystems.

Redfin Reports Listings and Sales Stumble as Sellers and Buyers Take Easter Break

Retrieved on: 
Thursday, April 4, 2024
Data Management, Technology, Other Construction & Property, Residential Building & Real Estate, Software, Construction & Property, Internet, Eye, Housing, Sale, Fed, Real estate

What sellers are doing: Year-over-year growth in new listings slowed because some sellers took a break over Easter, which fell over a week earlier in 2024 than in 2023.

Key Points: 
  • What sellers are doing: Year-over-year growth in new listings slowed because some sellers took a break over Easter, which fell over a week earlier in 2024 than in 2023.
  • Pending home sales fell 2.8% from a year ago, and they posted an unseasonal decline during the last week of March.
  • Some would-be buyers took a break from touring offers and making offers over Easter, and others are shying away due to high housing costs.
  • “Buyers may get a break on housing costs in the coming months,” said Redfin Economic Research Lead Chen Zhao.

Discover Tomorrow's Security Today: Solomon and Iveda Illuminate the Path with Machine Learning at ISC West 2024

Retrieved on: 
Wednesday, April 3, 2024
Software, Audio, Video, Artificial Intelligence, Robotics, Data Management, Technology, IOT (Internet of Things), Security, Learning, Intelligence, Land degradation, AI, Small business, Anomaly, Eye, ISC, IVDA, IP, RSVP, Safety, Machine learning, Android, Medical device

Iveda® (NASDAQ:IVDA), the global solution for cloud-based AI, is set to co-host two RSVP-only presentations at ISC West 2024 with core technology partner Solomon .

Key Points: 
  • Iveda® (NASDAQ:IVDA), the global solution for cloud-based AI, is set to co-host two RSVP-only presentations at ISC West 2024 with core technology partner Solomon .
  • Attendees will get hands-on experience, learning how AI can be used today in any operation to enhance safety, productivity, and more.
  • Join Iveda and Soloman to see how AI models can be trained to automatically detect and alert business leaders of anomalies and threats in real-time.
  • “These are not futuristic concepts, rather they’re practical applications that can be implemented today using the latest advancements in machine learning and AI.

New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease

Retrieved on: 
Friday, April 5, 2024
Health, Clinical Trials, Research, Science, Pharmaceutical, Optical, Biotechnology, Diagnosis, Pterygium, Disease, Eye, Conjunctiva, Safety, Physician, ASCRS, Air conditioning, Conjunctivitis, Tavarua, Tearing, Contact, Dry, Volunteering, Wind, Efficacy, Ophthalmology, Pollen, Chronic, Irritation, Pharmacokinetics, Vision, HCP, Recurrence, Pharma, Food

“Simple tasks like putting in contact lenses, applying makeup and using a computer or phone are made significantly more difficult, if not impossible, for those with pterygium.

Key Points: 
  • “Simple tasks like putting in contact lenses, applying makeup and using a computer or phone are made significantly more difficult, if not impossible, for those with pterygium.
  • As ophthalmologists, we need to listen closely to our patients and coordinate with optometrists to fully understand the impact of pterygium.
  • More information about this trial is available here: Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium .
  • The survey was designed with multiple-choice questions, rating questions and open-ended questions.2

Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)

Retrieved on: 
Wednesday, April 3, 2024
Medical Devices, Surgery, Health Technology, Health Insurance, Biotechnology, Managed Care, General Health, Pharmaceutical, Health, Optical, Retina, IOP, HCPCS, Glaucoma, Ocular hypertension, OAG, OHT, Patient, Corporation, APC, Eye, Surgeon, CPT, Travoprost, GKOS, OPPS, Idose, Medicare, CMS, Government, Intraocular pressure

The new J-code for iDose TR, J7355, is set to become effective July 1, 2024.

Key Points: 
  • The new J-code for iDose TR, J7355, is set to become effective July 1, 2024.
  • It is expected to increase patient access in the U.S. and has been published here on the CMS website.
  • “The receipt of a product-specific J-code for iDose TR supports our market access initiatives to enable broad access and coverage for patients suffering from open-angle glaucoma or ocular hypertension,” said Thomas Burns, Glaukos chairman and chief executive officer.
  • iDose TR is intended to improve the standard of care by addressing the ubiquitous patient non-compliance issues and chronic side effects associated with topical glaucoma medications.

National Donate Life Month Kicks Off Across Colorado & Wyoming

Retrieved on: 
Tuesday, April 2, 2024
General Health, Other Philanthropy, Health, Philanthropy, Transplant, Disease, Trauma, Life, Eye, Rocky, City, DMV, Heart, Paratriathlon, Injury

Raising a Donate Life flag is the cornerstone of National Donate Life Month.

Key Points: 
  • Raising a Donate Life flag is the cornerstone of National Donate Life Month.
  • When a donation occurs in a hospital, a Donate Life flag is often flown to honor the gift of life.
  • “The widespread show of support for National Donate Life Month continues to grow demonstrating how our region remains Rocky Mountain strong around this mission.
  • The heart with the Y on your driver license means you have joined the Donate Life Colorado or Donate Life Wyoming registry.

myFICO: 5 Tips to Help You Manage Multiple Credit Cards and Protect Your FICO® Scores

Retrieved on: 
Tuesday, April 2, 2024
Professional Services, Payments, Technology, Finance, Banking, Personal Finance, Wind, Risk, TransUnion, APR, Eye, Smartphone, Scores, FCRA, FICO, Credit

The average American has 3.84 credit cards according to Experian data, and some credit card rewards enthusiasts have many more.

Key Points: 
  • The average American has 3.84 credit cards according to Experian data, and some credit card rewards enthusiasts have many more.
  • Below are five helpful tips from myFICO to help you use multiple credit cards like a pro.
  • One of the first steps to managing multiple credit cards, indeed to managing your finances in general, is to create a budget .
  • Yet when you have multiple credit cards, monitoring your credit health may be even more critical than usual.

Toku Appoints Former Google Head of Cardiovascular Health as Chief Health Officer

Retrieved on: 
Tuesday, April 2, 2024
Health, Technology, Optical, Health Technology, Artificial Intelligence, Associate, Stanford University, Eye, American Heart, Multimedia, Research, Pharmaceutical industry

Toku is delighted to announce the appointment of Professor Michael V. McConnell, MD, MSEE to the role of Chief Health Officer.

Key Points: 
  • Toku is delighted to announce the appointment of Professor Michael V. McConnell, MD, MSEE to the role of Chief Health Officer.
  • Professor McConnell’s former roles include Director of Advanced Cardiovascular Imaging and Preventive Cardiology at Stanford University and Head of Cardiovascular Health Innovations at Google.
  • He is also a founding member of the American Heart Association’s Health Tech Advisory Group and author of Fight Heart Disease Like Cancer.
  • Mike combines clinical and research expertise, successful business experience, and a passion to have a global impact.